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To facilitate the diagnosis of enterotoxigenic Escherichia coli (ETEC) infections in humans, we developed and
evaluated real-time fluorescence PCR assays for the Roche LightCycler (LC) against the enterotoxin genes
commonly present in strains associated with human illness. Separate LC-PCR assays with identical
cycling conditions were designed for the type I heat-labile enterotoxin (LT I) and the type I heat-stable
enterotoxin (ST I) genes, using the LC hybridization probe format. A duplex assay for ST I with two sets
of amplification primers and three hybridization probes was required to detect the major nucleotide
sequence variants of ST I, ST Ia and ST Ib. LC-PCR findings from the testing of 161 E. coli isolates
of human origin (138 ETEC and 23 non-ETEC) were compared with those obtained by block cycler
PCR analysis. The sensitivities and specificities of the LC-PCR assays were each 100% for the LT I
and ST I genes. The LC-PCR and block cycler PCR assays were also compared for their abilities to detect
LT I and ST I genes in spiked stool specimens with different methods of sample preparation. Findings
from these experiments revealed that the limits of detection for the LC-PCR assays were the same or
substantially lower than those observed for the block cycler PCR assay. Melting curve analysis of the
amplified LT I and ST I genes revealed sequence variation within each gene, which for the ST I genes
correlated with the presence of ST Ia and ST Ib. The rapidity, sensitivity, and specificity of the LC-PCR
assays make them attractive alternatives to block cycler PCR assays for the detection and characterization
of ETEC.
Enterotoxigenic Escherichia coli (ETEC) is a major cause of
sporadic diarrheal disease in humans, affecting mainly children
in developing countries (1, 3, 21) and travelers from industri-
alized countries visiting tropical or subtropical areas (9).
ETEC strains have also caused waterborne outbreaks on cruise
ships (6), food-borne outbreaks at schools (16) and restaurants
(5, 11), and outbreaks among persons serving in the military
(12, 20, 27). ETEC strains from humans cause mild or severe
watery diarrhea by producing a heat-labile enterotoxin (LT I)
(similar in structure to cholera toxin), heat-stable enterotoxins
(ST Ia and/or ST Ib), or both (17).
Initially, detection of ETEC strains was accomplished with
animal assays and cell culture techniques that required specific
antibodies to reliably demonstrate the presence of the target
enterotoxins. Later, enzyme-linked immunosorbent assays
and membrane-based DNA hybridization assays, which im-
proved speed and ease of use, became popular. Further
enhancements in methods for the detection of ETEC gave
rise to PCR assays (18, 24, 26, 28). These assays were at-
tractive alternatives to the earlier methods because of their
sensitivity and specificity, as well as their speed and use of
readily available reagents. Recent advances in PCR ampli-
fication and fluorescence-based detection technologies have
brought significant improvements to conventional block cy-
cler PCR assays, thereby enabling the simultaneous, se-
quence-specific detection of multiple products in real time.
The development of thermal cyclers with the ability to rap-
idly amplify genes and the capacity to continuously monitor
the accumulation of specific PCR products labeled with
fluorescent probes obviates the need for labor-intensive aga-
rose gel procedures and provides a real-time, reliable iden-
tification of target genes (2, 7, 14, 15, 22, 23).
In the present study, we describe the development and eval-
uation of a set of real-time PCR assays for the LightCycler
(LC) (Roche Diagnostics, Mannheim, Germany), using prim-
ers and hybridization probes that target the LT I, ST Ia (also
referred to as STp), and ST Ib (also referred to as STh) genes.
We used the hybridization probe format for these assays be-
cause it permitted a melting curve analysis to be performed
after the amplification phase to achieve additional character-
ization of the target genes. The availability of rapid and specific
assays for the detection and characterization of ETEC should
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facilitate the detection and control of outbreaks caused by
ETEC.
MATERIALS AND METHODS
Bacterial strains. The E. coli strains included in this study were selected from
the culture collections of our institutions and are described in Table 1. We
studied 161 E. coli isolates, consisting of 138 ETEC and 23 non-ETEC strains,
and 168 strains from the following bacterial genera (the number of strains is in
parentheses): Treponema (1), Borrelia (3), Leptospira (1), Helicobacter (2), Le-
gionella (5), Neisseria (2), Branhamella (1), Xanthomonas (1), Moraxella (2),
Kingella (1), Acinetobacter (1), Sphingomonas (1), Pseudomonas (4), Brucella (2),
Bordetella (4), Shigella (4, including Shigella dysenteriae type 1), Salmonella (2),
Citrobacter (2), Klebisella (2), Enterobacter (2), Serratia (2), Proteus (2),
Morganella (1), Providencia (1), Yersinia (2), Vibrio (51, including 50 cholera
toxin-positive V. cholerae O1 and O139 strains), Aeromonas (1), Pasteurella (1),
Haemophilus (3), Actinobacillus (1), Bacteroides (1), Campylobacter (3), Fusobac-
terium (1), Eikenella (1), Prevotella (1), Porphyromonas (1), Rickettsia (1), Ehrli-
chia (1), Coxiella (1), Bartonella (2), Chlamydia (3), Mycoplasma (2), Ureaplasma
(1), Micrococcus (1), Staphylococcus (5), Streptococcus (5), Leuconostoc (1),
Pediococcus (1), Peptostreptococcus (3), Bacillus (2), Clostridium (3), Lactobacil-
lus (2), Listeria (1), Corynebacterium (5), Gardnerella (1), Propionibacterium (1),
Actinomyces (2), Mycobacterium (4), Nocardia (2), Tsukamorella (1), and Rhodo-
coccus (1). The ETEC strains were isolated from outbreaks investigated by the
Foodborne and Diarrheal Diseases Branch, Centers for Disease Control and
Prevention, Atlanta, Ga., during the period 1975 to 2002. The O:H serotypes and
presence of the genes for LT I, ST Ia, and ST Ib for the E. coli isolates are
summarized in Table 1.
Positive control strains included E. coli strains H10407 (serotype O78:H11),
containing the genes for LT I, ST Ia, and ST Ib; E2539 (serotype O25:NM),
containing the gene for LT I; TX1 (serotype O78:H12), containing the gene for
ST Ib; and B4106 (serotype O27:H7), containing the gene for ST Ia. Negative
control strains included the following diarrheagenic E. coli strains that lack the
LT and ST enterotoxin genes: Shiga toxin-producing E. coli ATCC 43895 (se-
rotype O157:H7), enteropathogenic E. coli B170 (serotype O111:NM), entero-
invasive E. coli EDL1284 (serotype O124:NM), and enteroaggregative E. coli
3591-78 (serotype O75:NM). Bacterial isolates were stored frozen at 70°C in
tryptic soy broth containing 10% glycerol and were subcultured prior to testing
on plates of either MacConkey agar (Merck, Darmstadt, Germany) or tryptic soy
agar containing 5% sheep blood.
Serologic characterization. Determination of O:H serotypes was performed by
standard methods, with the exception that the O serology was performed with
microtiter plates instead of tubes (8).
Preparation of template DNA. Template DNA from pure bacterial cultures
was prepared as previously described (23). Briefly, a 1-cm-long sweep of bacterial
growth from the quadrant of a blood or MacConkey agar plate with the heaviest
growth was suspended in 300 l of distilled water or 300 l of lysis buffer
composed of 1% Triton X-100, 0.5% Tween 20, 10 mM Tris-HCl (pH 8.0), and
1 mM EDTA and heated at 99.9°C for 10 min. In the case of overnight enrich-
ment broths, 500 l of broth was used for template preparation. After boiling,
the lysate was then centrifuged at 1,000  g for 2 min to sediment the debris.
Aliquots of the clear supernatant (2 to 5 l) were used as the source of template
DNA for the block cycler PCR and LC-PCR assays.
Template DNA from the spiked stool specimens was extracted directly from
sampling swabs by using the MagnaPure LC automated DNA extraction system
(Roche Diagnostics) with the total nucleic acid isolation kit (Roche Diagnostics).
Before processing in the automated DNA extraction system, the stool swabs were
immersed in 500 l of physiological saline and heated at 95°C for 10 min to
inactivate infectious material. For outbreak-associated stool specimens, which
were submitted as 50% (wt/vol) suspensions of stool in Cary-Blair transport
medium, the stool suspensions were diluted 1:3 with 0.01 M phosphate-buffered
saline and heated at 95°C for 10 min. A 200-l aliquot of the heated mixture was
then used as the sample for the automated extraction of template DNA. Aliquots
of the extracted DNA were used either directly for template DNA in the LC-
PCR assay or after a second heating at 99.9°C for 10 min in the block cycler PCR
assay.
Block cycler PCR assays. Detection and subtyping of LT I and ST I genes were
accomplished by using the block cycler PCR methods described by Ølsvik and
Strockbine (19) and Schultsz et al. (24). The method of Ølsvik and Strockbine
was used initially to test all strains for the presence of LT I and ST I genes. It
expanded the assay described by Olive (18) for LT I by adding a set of primers
for ST I. In this duplex assay, a 322-bp fragment for LT I was amplified with
primers LT1 (5-TCT CTA TGT GCA TAC GGA GC-3) and LT2 (5-CCA
TAC TGA TTG CCG CAA T-3), and a 147-bp fragment for ST I was amplified
with primers ST1 (5-TTA ATA GCA CCC GGT ACA AGC AGG-3) and ST2
(5-CTT GAC TCT TCA AAA GAG AAA ATT AC-3). A 5 l-aliquot of
supernatant was used unpurified as template DNA in a 50-l reaction mixture
consisting of 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, 0.01%
gelatin, 200 M deoxynucleoside triphosphates, 2 l of LT primer mix (50 M
each), 2 l of ST primer mix (100 M each), and 1.25 U of Taq DNA polymer-
ase. Amplification conditions were as follows: an initial denaturation step at 94°C
for 30 s; 35 cycles of denaturation at 95°C for 30 s, annealing at 60°C for 1 min,
and extension at 72°C for 1 min; and a final extension step at 72°C for 10 min.
The 161 E. coli strains (ETEC and non-ETEC) and any stool isolates that were
positive in the initial PCR assay were also tested in the PCR assay of Schultsz et
al. (24), which included three sets of primers for the detection of LT I (696-bp
amplification product), ST Ia (186-bp amplification product), and ST Ib (166-bp
amplification product), to confirm their enterotoxin genotype and to subtype the
ST I genes. A control containing water instead of template was included in each
experiment to exclude the possibility of reagent contamination. Amplified frag-
ments were separated by agarose gel electrophoresis and visualized after
ethidium bromide staining with UV illumination.
Oligonucleotide primers and fluorescence-labeled probes for the LC-PCR
assays. DNA oligonucleotide primers and hybridization probes were synthesized
by TIB Molbiol, Berlin, Germany, and by the Biotechnology Core Facility,
Centers for Disease Control and Prevention, Atlanta, Ga. Hybridization probes
were labeled with fluorescein, LC Red 640, or LC Red 705. The nucleotide
sequences of the primers and hybridization probes and their corresponding
TABLE 1. Characteristics of 138 ETEC and 23 non-ETEC strains tested by block cycler PCR and LC-PCR assays
Genotypea No. of
strains Serotype
b
LT I ST Ia ST Ib
   27 O6:31 (1), O8:H9 (1), O15:NM (1), O25:NM (2), O60:H9 (1), O63:NM (1), O64:NM (4), O78:H12 (1),
O127:H8 (1), O152:H2 (1), O159:H4/21 (3), O162:H28 (1), O166:H15 (1), O167:H5/Hund (2),
Ound:H7/H10/H15/H32/NM (5), Orou:H28 (1)
   33 O27:H7/H20/Hund (14), O99:NM (1), O159:NM (2), O169:H41/NM (14), Orou:H21 (1), Ound:NM (1)
   31 O6:H10 (1), O25:NM (15), O25:H42 (1), O27:H20 (1), O34:H10 (1), O49:NM (1), O63:H12 (1),
O78:H12 (2), O128:H7/H21/H27 (4), O135:H18 (1), O136:H12 (1), O148:H28 (1), O153:H45 (1)
   12 O17:NM (1), O24:NM (1), O64:Hund (1), O78:H11 (2), O99:H33 (1), O148:H28 (4), Ound:H10/NM
(2),
   32 O6:H16 (18), O8:H9 (1), O75:Hund (1), O78:H12/Hund (4), O148:H28 (5), O167:H5 (1), Orou:Hund
(1), Ound:Hund (1)
   3 O78:H11 (1), O148:H28 (2)
   23 O2:H4 (1), O103:H2 (1), O104:H28 (2), O111:NM (1), O123:H21 (1), O149:H7 (1), O154:H19 (1),
O157:H7 (8), Ound:Hund (2), Orou:H4/H7/H10/Hund/NM (6)
a The presence of the LT I, ST Ia, and ST Ib genes was determined by the block cycler PCR assays of Ølsvik and Strockbine (19) and Schultsz et al. (24).
b Ound and Hund, O and H antigens, respectively, not determined with available typing sera; Orou, O antigen not determined because of incomplete or rough
lipopolysaccharide; NM, nonmotile. Numbers in parentheses indicate the number of strains with that serotype.
VOL. 42, 2004 REAL-TIME PCR ASSAYS FOR ETEC LT I AND ST I GENES 4093
locations within the designated GenBank sequences are shown in Table 2. Oli-
gonucleotide sequences for the hybridization probes were selected by using Oligo
version 6.0 (Molecular Biology Insights, Inc., Cascade, Colo.) to have compara-
ble melting temperatures (Tms), GC contents within the range of 35 to 60
mol%, and minimal secondary structure due to self-complementarity or palin-
dromic sequences.
LC-PCR assay and product detection. All LC-PCR assays were performed
with a fluorescence temperature cycler (LC; Roche Diagnostics). The LT am-
plification mixture consisted of 2 l of 10 reaction mix (LC-FastStart master
hybridization probes; Roche Diagnostics), 3 mM MgCl2, a 0.5 M concentration
of each oligonucleotide primer, a 0.2 M concentration of each oligonucleotide
probe, and 2 l of template DNA in a final volume of 20 l. The ST amplification
mixture consisted of 2 l of 10 reaction mix (LC-FastStart master hybridization
probes; Roche Diagnostics), 3 mM MgCl2, 0.5 M ST Ia and 0.125 M ST Ih
oligonucleotide primers, a 0.2 M concentration of each oligonucleotide probe,
and 2 l of template DNA in a final volume of 20 l. Samples were amplified as
follows: an initial denaturation step at 95°C for 10 min to activate the FastStart
Taq DNA polymerase, 40 cycles of denaturation at 95°C for 10 s and annealing
at 50°C for 20 s, and an extension at 72°C for 30 s. The temperature transition
rate was 20°C/s. The generation of target amplicons for each sample was mon-
itored between the annealing and the elongation steps at 640 and 705 nm. At the
end of the quantification phase of the reaction, samples positive for target genes
were identified by the instrument at the cycle number where the fluorescence
attributable to the target sequences exceeded that measured for background.
Those scored as positive by the instrument were confirmed by visual inspection
of the graphical plot (cycle number versus fluorescence value) generated by the
instrument.
Following the amplification phase, a melting curve analysis was performed
with a temperature transition rate of 0.2°C/s to determine the Tms for the
sequences targeted by the hybridization probes. Tms were manually assigned
from a plot generated by the instrument of the negative derivative of fluores-
cence versus temperature (dF/dT) of the melting curve for amplification prod-
ucts measured at 640 and 705 nm. Positive controls were included in each LC run
to monitor any variation of melting peak temperature determined in different
runs. To avoid false-negative readings from possible variability in the target gene
sequences, the final determination of the presence of the target genes in samples
was performed at the completion of the melting curve analysis. Samples with
amplicons having Tms above those obtained for the negative control samples
(known negative strains and no-added-DNA template controls) were scored as
positive for the respective target gene.
Sensitivity of LC-PCR assays for ETEC detection. To assess the sensitivity of
the PCR assays for the three target genes, E. coli H10407 strain ATCC 35401 was
grown at 37°C in brain heart infusion broth (approximate optical density of 2.7
to 2.8 at 600 nm) and diluted 10-fold in phosphate-buffered saline to yield 101 to
1010 CFU/ml as estimated by a standard plating procedure. Crude DNA tem-
plates from a 300-l aliquot of each dilution were prepared by heating the
bacterial suspension at 99.9°C for 10 min to lyse the bacteria and centrifuging the
lysate at 1,000  g for 2 min to sediment debris. Aliquots of the clarified
supernatant were tested in the LC-PCR assays and the block cycler PCR assays
as described above to determine the minimum number of CFU per reaction that
could be detected by each method.
To assess the sensitivity of the PCR assays for the three target genes in fecal
specimens, aliquots of stool suspensions from four healthy volunteers (50%
[wt/vol] in physiological saline) were inoculated with E. coli H10407 to yield final
spiking levels of 100 to 107 CFU/g. Three swabs from each spiked stool suspen-
sion were prepared, and one swab from each spiking level was used to prepare
DNA templates for PCR by direct DNA extraction, culture on a MacConkey
agar plate (BBL, Cockeysville, Md.), or overnight enrichment in GN broth
(BBL). Whole-cell templates from the overnight growth on the MacConkey plate
and direct DNA extracts from the swabs were prepared as described above. The
DNA templates were tested with the block cycler and real-time PCR assays to
determine the limit of detection (LOD) for each assay. In this study, the LOD
was defined as the lowest inoculation level at which three of the four spiked stool
samples (75%) were positive.
Nucleotide sequence analysis of PCR products. Amplification products were
purified using the HighPure PCR product purification kit (Roche Diagnostics),
and cycle sequencing reactions for the LT I, ST Ia, and ST Ib amplicons were
performed as described in the PRISM Ready Reaction Dye Deoxy Terminator
cycle sequencing kit protocol (Applied Biosystems, Weiterstadt, Gemany). Both
strands of each amplicon originating from separate amplification reactions with
the corresponding primers listed in Table 2 were sequenced in duplicate to rule
out the possibility of Taq DNA polymerase-induced errors. The fluorescence-
labeled reaction products were analyzed with an ABI PRISM 310 genetic ana-
lyzer (Applied Biosystems).
Nucleotide sequence accession numbers. The nucleotide sequences of ampli-
cons derived from representative strains harboring LT I and ST I variants were
deposited in GenBank under the following accession numbers: AY342056 (strain
F5176, LT I variant), AY342057 (strain F7682, ST Ia variant), AY342058 (strain
C4046, ST Ib variant), and AY342059 (strain R554, ST Ib variant).
RESULTS
Strategy for duplex LC-PCR assay design. We designed two
separate real-time fluorescence PCR assays for the LC to de-
tect the two main types of enterotoxin genes commonly present
in ETEC strains causing human disease. One assay targets the
LT I gene, while the other targets the ST Ia and ST Ib genes.
For the LT I assay, primers spanning a 340-bp region of the
B-subunit gene and a set of hybridization probes (anchor and
sensor probes) internal to this region were designed against
sequences that were conserved among known LT I genes
(GenBank accession numbers M17874 and M17873) and that
were divergent from the analogous region of the cholera toxin
gene from Vibrio cholerae.
TABLE 2. Oligonucleotide primers and LC hybridization probes used in the PCR assay
Oligonucleotide Sequencea Targetgene
Nucleotide
position
GenBank
accession no. Reference
LTI-1 GCG TTA CTA TCC TCT CTA TGT G LT I 874–895 S60731 Klaus Pfeffer, personal
communication
LTI-2 AGT TTT CCA TAC TGA TTG CCG C LT I 1213–1192 S60731
LTI-HP-1 AGG ATG AAG GAC ACA TTA AGA ATC ACA T-[FL] LT I 1102–1129 S60731 Present study
LTI-HP-2 [Red 640]-TCT GAC CGA GAC CAA AAT TGA TAA ATT-[Ph] LT I 1131–1157 S60731 Present study
STIa-1 CTG TAT TAT CTT TCC CCT CT ST Ia 317–336 M25607 Present study
STIa-2 TTT AAT AAC ATG GAG CAC AG ST Ia 505–486 M25607 Present study
STIb-1 CTG TAT TGT CTT TTT CAC CT ST Ib 79–98 M34916 Present study
STIb-2 ATT AAT AGC ACC CGG TAC AA ST Ib 267–248 M34916 Present study
STI-HP-1a AAA TCA GAA AAT ATG AAC AAC ACA T-[FL] ST Ia 430–454 M25607 Present study
STI-HP-1b GTC CTG AAA GCA TGA ATA GTA GCA AT-[FL] ST Ib 193–218 M34916 Present study
STI-HP-2 [Red 705]-ACT GCT GTG AAT TGT GTT GTA ATC CT-[Ph] ST Ia 458–482 M25607 Present study
ST Ib 220–245 M34916
a [FL], fluorescein; [Red 640], LC-Red 640-N-hydroxy-succinimide ester; [Red 705], LC-Red 705-phosphoramidite; [Ph], 3- phosphate.
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Due to considerable sequence variation between the ST Ia
and ST Ib genes (homology of only 83.9% between the ST Ia
[GenBank accession number M25607] and ST Ib [GenBank
accession number M34916] sequences), we designed two sets
of primers targeting conserved regions between members of
each variant toxin type to give 189-bp amplicons for each gene.
From multiple-sequence alignments of the ST I genes (25), we
identified a 34-bp region internal to the primers with a high
degree of homology between ST Ia and ST Ib. We selected this
region to serve as the target sequence for a common anchor
hybridization probe (STI-HP-2) for both toxins. We designed
the sensor hybridization probes for ST Ia and ST Ib (STI-
HP-1a and STI-HP-1b, respectively) to differ from each other
in their theoretical Tms (4) in order to differentiate between
the presence of ST Ia and ST Ib by melting curve analysis. The
use of a common anchor probe reduced the complexity and
cost of the ST I multiplex by employing seven oligonucleotides
(four primers and three hybridization probes) instead of eight
oligonucleotides.
We designed the LT I and ST Ia/ST Ib LC-PCR assays to
have identical amplification conditions so that both could be
run simultaneously on the same instrument. Graphs depicting
the accumulation of fluorescence throughout the LC-PCRs for
LT I, ST Ia, and ST Ib are shown for a panel of representative
strains in Fig. 1. The curve for strain H10407, which is positive
for all three target genes, illustrates the clear discrimination
between target genes attainable with the LC-PCR assays.
Sensitivity and specificity of LC-PCR assays for detecting
target genes in pure bacterial cultures. To assess the ability of
the LC-PCR assays to detect LT I, ST Ia, and ST Ib entero-
toxin genes in a diverse collection of bacteria, we tested 161 E.
coli isolates and 168 isolates of other bacterial species, includ-
ing 51 strains of V. cholerae that are positive for the cholera
toxin genes, in the LC PCR assays and compared these findings
with those obtained by block cycler PCR assays. The correla-
tion of the LC-PCR and block cycler assays is shown in Table
3. There was complete correlation between the LC-PCR re-
sults and those obtained by the block cycler PCR assays.
Among the strains tested, the positive and negative predictive
values of the LC-PCR assays for LT I, ST Ia, and ST Ib were
each 100%. In scoring the results, it was important to complete
the melting curve analysis step of the LC-PCR assay to suc-
cessfully detect all the target genes. This was a factor for one
strain in the collection (F7682 [LT I negative, ST Ia positive,
ST Ib negative) (Fig. 1; see Fig. 3). The ST Ia gene present in
this strain was a sequence variant of ST Ia that was not de-
tected during the quantification step, in large part because its
optimal binding temperature for the hybridization probes was
below that used during the amplification assay. Because the
melting curve analysis extends over a lower temperature range
than that used during the amplification assay, this step in-
creases the sensitivity of the assay for detecting genes with
FIG. 1. Amplification of LT and ST genes in separate LC-PCR
assays. The graphs depict fluorescence at 640 and 705 nm versus cycle
number for E. coli strains with various combinations of target genes.
(A) LT genes. F, H10407 (LT I positive, ST Ia positive, ST Ib positive);
, F5176 (LT I positive, ST Ia negative, ST Ib negative); —, negative
control. (B) ST genes. F, H10407 (LT I positive, ST Ia positive, ST Ib
positive); ■, TX1 (LT I negative, ST Ia negative, ST Ib positive); ,
C4046 (LT I negative, ST Ia negative, ST Ib positive); , R554 (LT I
negative, ST Ia negative, ST Ib positive); E, F7682 (LT I negative, ST
Ia positive, ST Ib negative); —, negative control.
TABLE 3. Correlation of conventional PCR and LC-PCR results
for 329 bacterial isolates
Target
gene
No. of isolates with the following
conventional PCR/LCycler-PCR
results:
Sensitivity
(%)
Specificity
(%)
/ / / /
LT I 74 0 0 255 100 100
ST Ia 48 0 0 281 100 100
ST Ib 66 0 0 263 100 100
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sequence variability in the region of the hybridization probes.
In addition, the melting curve analysis also increases the sen-
sitivity of the assay for detecting target genes that have not
amplified sufficiently to be scored as positive after the quanti-
fication step. The benefit of this step in detecting samples with
weak amplification is attributable, in part, to the large number
of data points collected throughout the melting curve analysis,
in contrast to the limited number of readings that such samples
receive during the quantification step due to their shortened
log-linear phase.
Analytical sensitivity and specificity of the LC-PCR assays.
To determine the lower limit of detection for the LT I and ST
I LC-PCR assays, we performed each of the assays on DNA
preparations of reference strain H10407 at concentrations of
101 to 1010 CFU/ml in phosphate-buffered saline. Findings
from the LC-PCR assays and those performed in parallel with
the block cycler assay revealed a conservative lower limit of 102
organisms per reaction for the respective target genes in the
LC-PCR assays as well as the block cycler PCR assay.
Because of the complexity of the hybridization probe detec-
tion format for the variants of ST I, we assessed the ability of
the ST I LC-PCR assay to discriminate between the ST Ia and
ST Ib genes by testing DNA preparations from E. coli strains
that were positive for ST Ia, ST Ib, or both toxins in reaction
mixtures that contained the four ST I primer oligonucleotides
and either the ST Ia-specific or the ST Ib-specific pair of
hybridization probes. Clearly positive or negative amplification
curves were obtained, with no cross-reaction between the ST
Ia-positive strains and the ST Ib-specific set of hybridization
probes and vice versa. As expected, E. coli H10407, which is
positive for both ST Ia and ST Ib, was positive in both sets of
experiments.
Sensitivity of LC-PCR assays for detecting target sequences
in fecal specimens. The sensitivities of the LC-PCR and block
cycler PCR assays for detecting ETEC in spiked fecal speci-
mens from healthy donors were compared for the following
types of template DNA samples: DNA extracted directly from
the spiked fecal specimen, DNA released by boiling bacterial
growth from the primary isolation plate (MacConkey agar),
and DNA released by boiling of an aliquot of overnight en-
richment broth (GN broth). Findings from these experiments
are summarized in Table 4. The LODs for ETEC in fecal
specimens DNA extracted directly from the stool specimen was
used in the PCRs were 105 and 106 CFU/g for LT I and ST I,
respectively, in the LC-PCR assays and 107 CFU/g for both
target genes in the block cycler PCR assay. When DNA from
boiled bacterial growth from the MacConkey primary isolation
plate was used in the PCR, the LODs in the LC-PCR and block
cycler assays for both target genes were the same, 103 CFU/g.
Interestingly, when DNA from a boiled aliquot of overnight
enrichment broth was used in the PCRs, the LOD for the
LC-PCR assay was significantly improved, i.e., 1 CFU/g for LT
I and 10 CFU/g for ST I. A similar improvement in sensitivity
was observed for the block cycler PCR assay with the STI
target (LOD, 10 CFU/g) but not with the LT I target (LOD,
107 CFU/g). The LODs for ST Ia and ST Ib in the LC-PCR
assay were the same for all three experiments (data not
shown).
In addition to the spiked fecal specimens, six stool specimens
from persons who were part of an outbreak caused by ST
Ia-positive E. coli O27:H7 were tested for the presence of
ETEC in the LC-PCR and block cycler PCR assays. The find-
ings obtained with both methods by using sweeps of bacterial
growth from the primary isolation plates for DNA template
preparation agreed completely; three of six samples were pos-
itive for ST Ia, and three were negative. For the three positive
stool samples, positive findings for ST Ia genes were obtained
after approximately 40 min (cycles 23 to 27) in the LC-PCR, in
contrast to over 4 h in the block cycler PCR assay.
Time requirements for LC-PCR and block cycler PCR as-
says. We performed 40 amplification cycles for the LC-PCR
assays, which typically took 70 min to accomplish. For the
majority of samples (greater than 90% of isolates, enrichment
broths, and growth from primary isolation plates), however, we
could discriminate between PCR-positive and -negative sam-
ples after only 30 cycles, which took approximately 40 min to
accomplish. LT I and ST I target genes in DNA extracted
TABLE 4. Analytical sensitivity of the real-time and block cycler
PCR assays for detection of ETEC LT I and ST I genes from DNA
extracted directly from spiked stool samples (D), DNA extracted
from spiked stool samples cultured in GN broth (GN), and DNA
extracted from spiked stool samples cultured on MacConkey
agar (MC)
Inoculation
level
(CFU/g)
No. of positive samples/no. of samples analyzed
Real-time PCR Block cycler PCR
LT I ST Ia LT I ST Ia
D GN MC D GN MC D GN MC D GN MC
107 4/4 4/4 4/4 4/4 4/4 4/4 0/4 0/4 4/4 1/4 4/4 4/4
106 4/4 4/4 4/4 4/4 4/4 4/4 0/4 0/4 4/4 0/4 4/4 4/4
105 4/4 4/4 4/4 0/4 4/4 4/4 0/4 0/4 4/4 0/4 4/4 4/4
104 0/4 4/4 4/4 0/4 4/4 4/4 0/4 0/4 3/4 0/4 4/4 3/4
103 0/4 4/4 4/4 0/4 4/4 4/4 0/4 0/4 3/4 0/4 4/4 3/4
102 0/4 4/4 0/4 0/4 4/4 0/4 0/4 0/4 0/4 0/4 4/4 0/4
101 0/4 4/4 0/4 0/4 4/4 0/4 0/4 0/4 0/4 0/4 4/4 0/4
100 0/4 4/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4
a ST Ia and ST Ib were detected with equal sensitivity.
TABLE 5. Distribution of Tms among 137 ETEC strains and
associated sequence variation in the region of the
hybridization probes
Target gene
(no. of strains
positive for
target gene)
Tm
(°C)
(1°C)
No. of
strains
having
designated
Tm
No. of nucleotide
differences between
target gene and
probesa
Representative ETEC
strain(s) sequenced
LT I (74) 62 67 0 H10407 (O78:H11),
E2539 (O25:NM)
60 7 1 F5176 (O167:H5)
ST Ia (48) 57 47 0 H10407 (O78:H11)
49 1 3 F7682 (O136:H12)
ST Ib (66) 64 59 0 H10407 (O78:H11),
TX1 (O78:H12)
62 6 1 C4046 (O148:H28)
59 1 1 R554 (O25:H42)
a Number of nucleotide differences between the target gene sequences of
representative strains at each Tm and the corresponding hybridization probe
sequences.
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directly from stool specimens at 105 and 106 CFU/g, respec-
tively, typically required 35 to 38 cycles to detect. Block cycler
PCR assays with agarose gel detection of amplicons typically
took 4.5 to 5 h to complete. If a sequence-based identification
of amplicons from the block cycler was performed, the block
cycler assay would require 7 to 18 h, depending on the format
of the detection assay (enzyme immunoassay or membrane-
based hybridization with DNA probes).
Differentiation of LT, ST Ia, and ST Ib variants by melting
curve analysis. Sharp and clearly interpretable melting curves
(plotted as the negative derivative of fluorescence versus
temperature) were obtained with all 138 ETEC isolates
tested. Findings from the melting curve analyses of these
isolates and the representative isolates sequenced for each
Tm are summarized in Table 5. In the course of this study,
the interassay precision of the LC melting curve analysis was
1°C. Melting curve profiles of representative strains and
the sequences of their target genes at the annealing region
of the hybridization probes are shown in Fig. 2 and 3. A
predominant Tm was detected for each of the target genes.
The Tms of the control strains for LT I, ST Ia, and ST Ib
were 62, 57, and 64°C, respectively. These Tms reflect com-
plete homology between the hybridization probes and their
target sequences.
A small number of strains possessed genes with sequence
variation in the region of the hybridization probes. We noted a
reduced Tm of 60°C for seven LT I-positive strains, a Tm of
49°C for one ST Ia strain, and Tms of 62 and 59°C for six ST Ib
strains and one ST Ib strain, respectively (Table 5). Sequencing
data obtained for the amplicons of representative strains at
each Tm showed one to three nucleotide mismatches per strain
between the target sequence and that of the hybridization
probes. In general, there was a correlation between the num-
ber of mismatches between the target and probe sequences
FIG. 2. (A) Melting curve analysis performed on amplification products of two different LT-positive isolates. Strain H10407 represents a typical
LT I-positive isolate, and strain F51761 is an ETEC isolate harboring a variant LT I sequence. (B and C) Sequence alignments with amplicons of
the two different LT I-genotypes, the sequence under GenBank accession number S60731, and sensor hybridization probe LT-HP-1 (B) or anchor
hybridization probe LT-HP-2 (C). Sequence identity is indicated by dashes. The observed Tms are indicated.
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FIG. 3. (A) Melting curve analysis performed on amplification products of four different ST-positive isolates, representative of the different ST
genotypes observed in this study. Strain H10407 represents a typical ST Ia-positive and ST Ib-positive isolate, strain F7682 is an isolate harboring
a variant ST Ia sequence, and strains C4046 and R554 are ST Ib-positive isolates harboring variant ST Ib sequences. (B and C) Sequence
alignments with amplicons of the four different ST-genotypes; the sequences under GenBank accession numbers M25607 (ST Ia), M34916 (ST Ib),
and M18345 (variant ST Ib); and ST Ia-specific sensor hybridization probe ST-HP-1a (B), ST Ib-specific sensor hybridization probe ST-HP-1b (B),
or anchor hybridization probe ST-HP-2 (C). Sequence identity is indicated by dashes. The observed Tms are indicated.
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and the degree to which the Tms of the variant strains were
depressed relative to strains with target sequences completely
homologous to the probes. In several cases the nucleotide
changes resulted in amino acid changes; however, the effect of
these changes on protein function is not known (10, 13).
DISCUSSION
We focused on the development of a reliable real-time PCR
assay for the detection of LT I and ST I genes. Our set of
real-time fluorescence PCR assays for LT I, ST Ia, and ST Ib
covers the enterotoxin genes commonly associated with human
disease. In the process of evaluating our assay, we by chance
discovered a number of heretofore-unknown mutations within
the amplification products of several ETEC strains tested. The
sequences of the variant enterotoxin amplicons have been de-
posited in GenBank to help guide future assay development.
Although the variants we detected were the exception and not
the rule among the diverse collection of strains examined in
this study, the presence of sequence variation in the toxins
illustrates the advantage of the hybridization probe format and
melting curve analysis for providing strain characterization
over traditional block cycler PCR or other real-time PCR for-
mats that lack the capacity for melting curve analyses. Strains
with unusual Tms will be easy to monitor and track if they are
to cause an outbreak.
After evaluating the separate LT I and ST I LC-PCR assays,
we attempted to combine them into a single multiplex reaction
with six primer and five hybridization probe oligonucleotides in
one capillary. The presence of LT I-specific genes was detected
at 640 nm (channel F2), and the presence of ST I-specific genes
was detected at 705 nm (channel F3). A melting curve analysis
was performed to resolve the ST Ia and ST Ib variants. Al-
though conditions that permitted the simultaneous detection
and differentiation of the three target genes in a single reaction
were identified (final concentrations of 5 mM MgCl2 and 0.2
M primers LT-1 and LT-2), the sensitivity of the assay was
observed to be affected by slight deviations in primer oligonu-
cleotide concentrations that can routinely occur among differ-
ent batches of commercially synthesized oligonucleotides. For
this reason, we do not recommend combining the present as-
says in a single capillary for routine diagnostic testing.
Since the rational design of probes for microarray systems is
based on a comprehensive database of nucleotide sequences, a
potential use for the enterotoxin LC-PCR assays is to screen
strains to identify sequence variants of the enterotoxin genes.
In this study, the melting curve analysis proved to be a very
efficient method for identifying a small number of strains with
variant enterotoxin genes for subsequent sequencing to de-
velop DNA array-based assays.
Findings from the experiment with spiked stool specimens
revealed significant variation in the LODs for the LC-PCR and
block cycler PCR assays with the three different methods of
template DNA preparation and highlight the importance of
this single step for the performance of the PCR assays. The
LODs for both target genes in the LC-PCR and for the ST
genes in the block cycler PCR assays were lowest with DNA
templates prepared from the overnight GN enrichment broths.
The failure of the block cycler PCR assay to detect the LT
genes from the GN broth was unexpected and illustrates the
unpredictable nature of PCR assays. Experiments to determine
if a component in the GN broth may be responsible for this
selective inhibition are planned.
The LODs for the LC-PCR and block cycler PCR assays
were similar to each other when overnight growth from the
MacConkey plate was used to prepare the DNA templates.
Interestingly, these values were 100- to more than 1,000-fold
higher that those from the overnight GN broth culture. The
reason(s) for this is not clear. Possible factors that may have
affected the sensitivity of these assays include inhibitors carried
over from the agar, slower growth characteristics of the target
bacterium relative to nontarget bacteria on MacConkey agar
compared with GN broth, and denser cell suspensions pre-
pared from the agar plates than from the GN broth, resulting
in too much DNA being added to the PCR mixture.
The highest LODs were observed for the DNA template
preparation extracted directly from stool; the LC-PCR assay
was 100 to 1,000 times more sensitive than the block cycler
PCR assay for detecting the ST I and LT I genes, respectively.
In comparison with block cycler PCR assays, this difference
offers a potential advantage for LC-PCR assays for rapidly
diagnosing ETEC infections, by allowing detection of ETEC
without enrichment in samples containing 105 to 106 CFU/g.
The practical benefit of this difference is not clear, as the
percentage of diarrheal specimens with ETEC in this range is
not known.
The combination of simplex LT I-specific and duplex ST
I-specific LC-PCR assays described in this report offers rapid
cycling (1 h or less) with real-time, sequence-specific detection
of amplicons. The fluorescence-labeled hybridization probes
not only provide confidence in the identification of target
genes but also reduce the risk of product contamination of the
laboratory because the amplification reaction, detection of
PCR products, and melting curve analyses are conducted in a
single closed capillary tube. Although our current protocol for
processing stool specimens for ETEC requires an overnight
enrichment step in GN broth to achieve optimal sensitivity, the
rapid amplification and reliable detection of the prototype LT
I and ST I genes, and variants thereof, in samples should
facilitate the diagnosis of individuals infected with ETEC.
While the diagnosis and management of individual patients
infected with ETEC do not require an isolate, the isolation of
ETEC from patient samples is critical for public health pur-
poses. The association of the ETEC target genes with a par-
ticular bacterium requires testing of isolates, and isolates are
still needed for molecular subtyping (DNA fingerprinting) and
serologic characterization for surveillance purposes. For these
reasons, clinical laboratories are strongly encouraged to con-
sult with their public health authorities for guidance on for-
warding positive samples for isolation of ETEC. The speed
with which bacterial colonies can be screened for target genes
and these genes can be characterized with the LC-PCR assays
should facilitate the detection and investigation of ETEC out-
breaks. Although LC-PCR assays are currently more expensive
to perform than block cycler PCR assays, their speed, reduced
hands-on time, and greater information and the reliability of
the results make them attractive alternatives to conventional
block cycler PCR assays for the detection and characterization
of ETEC.
VOL. 42, 2004 REAL-TIME PCR ASSAYS FOR ETEC LT I AND ST I GENES 4099
ACKNOWLEDGMENTS
We thank Norbert Lehn and Stefan Lukas for their active support
and Klaus Pfeffer (Institute of Medical Microbiology, University of
Düsseldorf, Düsseldorf, Germany) for consultation in the design of the
LT I primers. We gratefully acknowledge the excellent technical assis-
tance of Markus Bollwein and Michaela Hien during the study.
This work has been supported in part by the Arab Fund for Eco-
nomic and Social Development, Kuwait. M.T.Y. was a recipient of the
Arab Fund’s distinguished Scholar Award.
REFERENCES
1. Albert, M. J., S. M. Faruque, A. S. G. Faruque, P. K. Neogi, M. Ansaruzza-
man, N. A. Bhuiyan, K. Alam, and M. S. Akbar. 1995. Controlled study of
Escherichia coli diarrheal infections in Bangladeshi children. J. Clin. Micro-
biol. 33:973–977.
2. Bellin, T., M. Pulz, A. Matuseek, H.-G., Hempen, and F. Gunzer. 2001.
Rapid detection of enterohemorrhagic Escherichia coli by real-time PCR
with fluorescent hybridization probes. J. Clin. Microbiol. 39:370–374.
3. Black, R.E. 1986. The epidemiology of cholera and enterotoxigenic Esche-
richia coli diarrheal disease, p. 23–32. In J. Holmgren, A. Lindberg, and R.
Mollby (ed.), Development of vaccine and drug against diarrhea. Eleventh
Nobel Conference, Stockholm. Studentlitteratur, Lund, Sweden.
4. Breslauer, K. J., R. Frank, H. Blocker, and L. A. Marky. 1986. Predicting
DNA duplex stability from the base sequence. Proc. Natl. Acad. Sci. USA
83:3746–3750.
5. Centers for Disease Control and Prevention. 1994. Foodborne outbreaks of
enterotoxigenic Escherichia coli—Rhode Island and New Hampshire. Morb.
Mortal. Wkly. Rep. 43:81–89.
6. Daniels, N. A., J. Neimann, A. Karpati, U. D. Parashar, K. D. Greene, J. G.
Wells, A. Srivastava, R. V. Tauxe, E. D. Mintz, and R. Quick. 2000. Travel-
er’s at the sea: three outbreaks of waterborne enterotoxigenic Escherichia
coli on cruise ships. J. Infect. Dis. 181:1491–1495.
7. Edwards, K. J., L. A. Metherell, M. Yates, and N. A. Saunders. 2001.
Detection of rpoB mutations in Mycobacterium tuberculosis by biprobe anal-
ysis. J. Clin. Microbiol. 39:3350–3352.
8. Ewing, W. H. 1986. The genus Escherichia, p. 93–134. In Edwards and
Ewing’s identification of Enterobacteriaceae, 4th ed. Elsevier Science Pub-
lishing Co., Inc., New York, N.Y.
9. Gorbach, S. L., B. H. Kean, D. G. Evans, D. G. Evans, Jr., and D. Bessudo.
1975. Traveller’s diarrhea and toxigenic Escherichia coli. N. Engl. J. Med.
292:933–936.
10. Guzman-Verduzio, L. M., and Y. M. Kupersztoch. 1989. Rectification of two
Escherichia coli heat-stable enterotoxin allele sequences and lack of biolog-
ical effect of the change of the carboxy-terminal tyrosine for histidine. Infect.
Immun. 57:645–648.
11. Hedberg, C. W., S. J. Savarino, J. M. Besser, C. J. Paulus, V. M. Thelen, L. J.
Myers, D. N. Cameron, T. J. Barrett, J. B. Kaper, M. T. Osterholm, et al.
1997. An outbreak of foodborne illness caused by Escherichia coli O39:NM,
an agent not fitting into the existing scheme for classifying diarrheagenic E.
coli. J. Infect. Dis. 176:1625–1628.
12. Huerta, M., I. Grotto, M. Gdalevich, D. Mimouni, B. Gavrieli, M. Yavzori, D.
Cohen, and O. Shiplberg. 2000. A waterborne outbreak of gastroenteritis in
the Golan Heights due to enterotoxigenic Escherichia coli. Infection 28:267–
271.
13. Inoue, T., T. Tsuji, M. Koto, S. Imamura, and A. Miyama. 1993. Amino acid
sequence of heat-labile enterotoxin from chicken enterotoxigenic Esche-
richia coli is identical to that of human strain H 10407. FEMS Microbiol.
Lett. 108:157–161.
14. Logan, J. M., K. J. Edwards, N. A. Saunders, and J. Stanley. 2001. Rapid
identification of Campylobacter spp. by melting peak analysis of biprobes in
real-time PCR. J. Clin. Microbiol. 39:2227–2232.
15. Maguire, A. L., D. F. J. Brown, J. J. Gray, and U. Desselberger. 2001. Rapid
screening technique for class 1 integrons in Enterobacteriaceae and nonfer-
menting gram-negative bacteria and its use in molecular epidemiology. An-
timicrob. Agents Chemother. 45:1022–1029.
16. Mitsuda, T., T. Muto, M. Yamada, N. Kobayashi, M. Toba, Y. Aihara, A. Ito,
and S. Yokota. 1998. Epidemiological study of food-borne outbreak of en-
terotoxigenic Escherichia coli O25:NM by pulsed-field gel electrophoresis
and randomly amplified polymorphic DNA analysis. J. Clin. Microbiol. 36:
652–656.
17. Moseley, S. L., J. W. Hardy, M. I. Huq, P. Echeverria, and S. Falkow. 1983.
Isolation and nucleotide sequence determination of a gene encoding a heat-
stable enterotoxin of Escherichia coli. Infect. Immun. 39:1167–1174.
18. Olive, M. 1989. Detection of enterotoxigenic Escherichia coli after polymer-
ase chain reaction amplification with a thermostable DNA polymerase.
J. Clin. Microbiol. 27:261–265.
19. Ølsvik O., and N. A. Strockbine. 1993. PCR detection of heat-stable, heat-
labile, and Shiga-like toxin genes in Escherichia coli, p. 271–276. In D. H.
Persing, T. F. Smith, F. C. Tenover, and T. J. White (ed.), Diagnostic
molecular microbiology. American Society for Microbiology, Washington,
D.C.
20. Oyofo, B. A., L. F. Peruski, T. F. Ismail, S.H. el-Etr, A. M. Churilla, M. O.
Wasfy, B. P. Petrucelli, and M. E. Gabriel. 1997. Enteropathogens associated
with diarrhea among military personnel during Operation Bright Star 96, in
Alexandria, Egypt. Milit. Med. 162:396–400.
21. Paniagua, M., F. Espinoza, M. Ringman, E. Reizenstein, A. M. Svenner-
holm, and H. Hallander. 1997. Analysis of incidence of infection with ente-
rotoxigenic Escherichia coli in a prospective cohort study of infant diarrhea
in Nicaragua. J. Clin. Microbiol. 35:1404–1410.
22. Reischl, U., H. J. Linde, M. Metz, B. Leppmeier, and N. Lehn. 2000. Rapid
identification of methicillin-resistant Staphylococcus aureus and simulta-
neous species confirmation using real-time fluorescence. J. Clin. Microbiol.
38:2429–2433.
23. Reischl, U., M. T. Youssef, J. Kilwinski, N. Lehn, W. L. Zhang, H. Karch,
and N. A. Strockbine. 2002. Real-time fluorescence PCR assays for the
detection and characterization of Shiga toxin, intimin, and enterohemolysin
genes from Shiga toxin-producing Escherichia coli. J. Clin. Microbiol. 40:
2555–2565.
24. Schultsz, C., G. J. Pool, R. van Ketel, B. de Wever, P. Speelman, and J.
Dankert. 1994. Detection of enterotoxigenic Escherichia coli in stool samples
by using nonradioactively labeled oligonucleotide DNA probes and PCR.
J. Clin. Microbiol. 32:2393–2397.
25. Sekizaki, T., H. Akashi, and N. Terakado. 1985. Nucleotide sequences of the
genes for Escherichia coli heat-stable enterotoxin I of bovine, avian, and
porcine origins. Am. J. Vet. Res. 46:909–912.
26. Tsen, H.-Y., and L.-Z. Jian. 1998. Development and use of a multiplex PCR
system for the rapid screening of heat-labile toxin I, heat-stable toxin II and
Shiga-like toxin I and II genes of Escherichia coli. J. Appl. Microbiol. 84:
585–592.
27. Wilshaw, G. A., T. Cheasty, B. Rowe, H. R. Smith, D. N. Faithful-Davies, and
T. G. J. Brooks. 1995. Isolation of enterotoxigenic Escherichia coli from
British troops in Saudi Arabia. Epidemiol. Infect. 115:455–463.
28. Yavzori, M., N. Porath, O. Ochana, R. Dagan, R. Orni-Wasserlauf, and D.
Cohen. 1998. Detection of enterotoxigenic Escherichia coli in stool speci-
mens by polymerase chain reaction. Diagn. Microbiol. Infect. Dis. 31:503–
509.
4100 REISCHL ET AL. J. CLIN. MICROBIOL.
